- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 141 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- September 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 254 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2025
- 120 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2025
- 150 Pages
Global
From €3538EUR$3,950USD£3,016GBP
- Report
- May 2025
- 181 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- June 2025
- 78 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 279 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 287 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 374 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- January 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- August 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- April 2025
- 201 Pages
Global
From €4474EUR$4,995USD£3,814GBP
- Report
- July 2024
- 119 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- February 2023
- 258 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- August 2023
- 313 Pages
Global
From €3762EUR$4,200USD£3,207GBP

The Infection Surveillance Solutions market is a subset of the Infectious Disease Testing market, focusing on the development of solutions to monitor and track the spread of infectious diseases. These solutions are designed to provide healthcare professionals with the data and insights they need to identify and respond to potential outbreaks. Solutions may include software, hardware, and services that enable the collection, analysis, and sharing of data related to infectious diseases.
The Infection Surveillance Solutions market is driven by the need to improve public health outcomes and reduce the economic impact of infectious diseases. Governments, healthcare providers, and other stakeholders are increasingly investing in solutions to better understand and respond to the spread of infectious diseases.
Companies in the Infection Surveillance Solutions market include IBM, Epic Systems, Cerner Corporation, Allscripts, and Athenahealth. Show Less Read more